Arcturus Therapeutics has extended an existing agreement in place with the Cysti...
MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substan...
Alfasigma has signed a definitive agreement for the acquisition of Intercept Pha...
The popular acne treatment will soon be available in 15 EU countries in addition...
The funding was part of an oversubscribed Series C financing that will be used t...
Apart from the workforce cuts, the company is also considering asset divestment ...
The partnership will help advance preclinical concept in the cardiometabolic dis...
The idiopathic pulmonary fibrosis (IPF) market is underserved with just two lice...
With GlobalData figures showing the value of pharma’s 2023 digital therapeutics-...
UKHSA has signed an advance purchase agreement (APA) with healthcare company CSL...
“The truth is in many ways and many places, women have very little choice to obt...
After a drawn out lobbying fight, ARPA-H chose its headquarters: a hub and spoke...
Humira made an average $14.6 billion a year after the end of its primary patent,...
Sen. Bob Menendez (D-N.J.), who's embroiled in a financial scandal, is one of th...
Cambridge, Dallas, and Washington, D.C. were chosen as the three national hubs f...
There are a slew of federal programs and staff that could see work stalled this ...
